整理番号

論文の種類

著者名

タイトル

雑誌名
書名　外

巻（号）

ページ

年号

Correns-ponding
Author

1462001

原著

Otsu S, Watanabe K, Morinaga R, Hirashima Y, Nishikawa K,
Sakashita H, Shirao K.

Neurological toxicity in metastatic colorectal cancer patients treated with modifiedFOLFOX6 plus bevacizumab.

Japanese Clin Med.

5,

19-23,

2014

1462002

原著

Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K.

Erratum to :identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.

Ann Surg Oncol.

20,

598-590,

2014.

1462003

原著

Sasaki Y, Hamaguchi T, Arai T, Goto A, Ura T, Muro K, Yamada Y, Shirao K, Shimada Y.

Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectalcancer in japanese patients.

Anticancer Res.

34(4),

2029–2034,

2014.

1462004

原著

Takashima A, Boku N, Kato K, Nakamura K, Mizusawa J, Fukuda H, Shirao K, Shimada Y, Ohtsu A.

Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer.

Gastric Cancer.

17(3),

522–528,

2014.

1462005

原著

Takahari D, Hamaguchi T, Yoshimura K, Katai H, Ito S, Fuse N, Konishi M, Yasui H, Terashima M, Goto M, Tanigawa N, Shirao K, Sano T, Sasako M.

Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.

Gastric Cancer.

17(2),

383-386,

2014.

1462006

原著

Hayashi H, Arao T, Matsumoto K, Kimura H,Togashi Y, Hirashima Y, et al.

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma.

Oncotarget.

5(9),

2588-2595,

2014.

1462007

原著

Toriumi N, Kobayashi R, Yoshida M, Iguchi A, Sarashina T, Okubo H, Suzuki D, Sano H, Ogata M, Azuma H.

Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.

J Pediatr Hematol Oncol 22014.

36 (5),

379-383,

2014.

1462008

原著

Maie K, Fuji S, Tajima K, Tatsuno M, Yamagata S, Takahashi N, Ueda R, Hashimoto H, Takano K, Inoue Y, Ito A, Hayashi Y, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Heike Y, Yamashita T, Fukuda T.

A higher number of infused CD34 (+) cells has a positive impact on the clinical outcome after related PBSC transplantation.

Bone Marrow Transplant.

49(8),

1113-1115,

2014.

1462009

原著

Sakurai M, Mori T, Kato J, Koda Y, Kikuchi T, Kohashi S, Saburi M, Toyama T, Aisa Y, Nakazato T, Beppu N, Tsuda S, Shigematsu N, Okamoto S.

Efficacy of aprepitant in preventing nausea and vomiting due to high-dose melphalan-based conditioning for allogeneic hematopoietic stem cell transplantation.

Int J Hematol.

99(4),

457-462,

2014.

1462010

原著

Mori T, Shimizu T, Kato J, Kikuchi T, Kohashi S, Koda Y, Toyama T, Saburi M, Iketani O, Okamoto S.

Nephrotoxicity of concomitant use of tacrolimus and teicoplanin in allogeneic hematopoietic stem cell transplant recipients.

Transpl Infect Dis.

16(2),

329-332,

2014.

1462011

原著

Fuji S, Takano K, Mori T, Eto T, Taniguchi S, Ohashi K, Sakamaki H, Morishima Y, Kato K, Miyamura K, Suzuki R, Fukuda T.

Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT.

Bone Marrow Transplant.

49(12),

1505-1512,

2014.

1462012

原著

Kohashi S, Mori T, Hashida R, Kato J, Saburi M, Kikuchi T, Koda Y, Toyama T, Yamane Y, Yamanaka S, Okamoto S.

Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.

Int J Hematol.

101(1),

102-105,

2014.

1462013

原著

菊池拓、森毅彦,甲田裕也,佐分利益穂,小橋澄子,外山高朗,加藤　淳,橋本統,中塚誠之,海老沼浩利,岡本真一郎.

同種造血幹細胞移植患者における経内頸静脈的肝生検の安全性と有効性の検討　
Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients

臨床血液.

55,

2320-2323,

2014.

1462013

原著

Suzuki Y, Tokimatsu I, Morinaga Y, Sato Y, Takano K, Kohno K, Ogata M, Hiramatsu K, Itoh H, Kadota JI.

A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy.

Clin Chim Acta.

440

7-183,

2014.

1462014

症例報告

Tokuyama K, Okada F, Matsumoto S, Mori H, Ogata M, Omote E, Yamasaki T, Urabe S.

EBV-positive MTX-diffuse large B cell lymphoma in a rheumatoid arthritis patient

Jpn J Radiol.

32,

183-187,

2014.

1462015

症例報告

佐分利益穂,井谷和人,長松顕太郎,宮崎泰彦,大塚英一,卜部省吾,佐分利能生.

Methotrexate/cytarabine大量療法が奏功したSMILE療法抵抗性の節外性NK/T細胞リンパ腫、鼻型.

臨床血液.

55,

120-124,

2014.

1462016

症例報告

油田さや子、森毅彦、加藤淳、甲田裕也、小橋澄子、菊池拓、佐分利益穂、岡本真一郎

同種造血幹細胞移植後のtacrolimusによるナトリウム喪失性腎症.

臨床血液.

54,

2187-191,

2013.

1462017

総説

宮崎泰彦.

Peg-G-CSF製剤への期待.

血液フロンティア.

24,

80-84,

2014.

1462018

総説

池邉太一.

臍帯血移植後早期のウイルス感染症-克服するべき合併症と虎の門病院での取り組み.

医学のあゆみ.

249(7),

594-599,

2014.

1462019

総説

緒方正男.

同種造血細胞移植後のHHV-6再活性化と脳炎.

血液内科.

68 (5),

682-688,

2014.

1462020

著書

平島　詳典,白尾　國昭.

がんに対する薬の使い方.

MEDICAL REHABILITATION.

no.178,

70-74,

2014.

1462021

著書

佐分利益穂,森毅彦.

造血幹細胞移植に特有な合併症.

血液病学.

第2版、第5章:血液疾患の治療 / C造血幹細胞移植,

256-264,

2014.

1462022

著書

Zerr DM , Ogata M.

HHV-6A and HHV-6B in recipients of hematopoietic cell transplantation.

Human Herpesviruses HHV-6A, HHV-6B & HHV-7, Diagnosis and Clinical Management, third edition Chapter 13.

217-229,

2014.

腫瘍・血液内科学
Medical Oncology and Hematology
整理番号	論文の種類	著者名	タイトル	雑誌名書名　外	巻（号）	ページ	年号	Correns-ponding Author
1462001	原著	Otsu S, Watanabe K, Morinaga R, Hirashima Y, Nishikawa K, Sakashita H, Shirao K.	Neurological toxicity in metastatic colorectal cancer patients treated with modifiedFOLFOX6 plus bevacizumab.	Japanese Clin Med.	5,	19-23,	2014
1462002	原著	Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K.	Erratum to :identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.	Ann Surg Oncol.	20,	598-590,	2014.
1462003	原著	Sasaki Y, Hamaguchi T, Arai T, Goto A, Ura T, Muro K, Yamada Y, Shirao K, Shimada Y.	Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectalcancer in japanese patients.	Anticancer Res.	34(4),	2029–2034,	2014.
1462004	原著	Takashima A, Boku N, Kato K, Nakamura K, Mizusawa J, Fukuda H, Shirao K, Shimada Y, Ohtsu A.	Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer.	Gastric Cancer.	17(3),	522–528,	2014.
1462005	原著	Takahari D, Hamaguchi T, Yoshimura K, Katai H, Ito S, Fuse N, Konishi M, Yasui H, Terashima M, Goto M, Tanigawa N, Shirao K, Sano T, Sasako M.	Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.	Gastric Cancer.	17(2),	383-386,	2014.
1462006	原著	Hayashi H, Arao T, Matsumoto K, Kimura H,Togashi Y, Hirashima Y, et al.	Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma.	Oncotarget.	5(9),	2588-2595,	2014.
1462007	原著	Toriumi N, Kobayashi R, Yoshida M, Iguchi A, Sarashina T, Okubo H, Suzuki D, Sano H, Ogata M, Azuma H.	Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.	J Pediatr Hematol Oncol 22014.	36 (5),	379-383,	2014.
1462008	原著	Maie K, Fuji S, Tajima K, Tatsuno M, Yamagata S, Takahashi N, Ueda R, Hashimoto H, Takano K, Inoue Y, Ito A, Hayashi Y, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Heike Y, Yamashita T, Fukuda T.	A higher number of infused CD34 (+) cells has a positive impact on the clinical outcome after related PBSC transplantation.	Bone Marrow Transplant.	49(8),	1113-1115,	2014.
1462009	原著	Sakurai M, Mori T, Kato J, Koda Y, Kikuchi T, Kohashi S, Saburi M, Toyama T, Aisa Y, Nakazato T, Beppu N, Tsuda S, Shigematsu N, Okamoto S.	Efficacy of aprepitant in preventing nausea and vomiting due to high-dose melphalan-based conditioning for allogeneic hematopoietic stem cell transplantation.	Int J Hematol.	99(4),	457-462,	2014.
1462010	原著	Mori T, Shimizu T, Kato J, Kikuchi T, Kohashi S, Koda Y, Toyama T, Saburi M, Iketani O, Okamoto S.	Nephrotoxicity of concomitant use of tacrolimus and teicoplanin in allogeneic hematopoietic stem cell transplant recipients.	Transpl Infect Dis.	16(2),	329-332,	2014.
1462011	原著	Fuji S, Takano K, Mori T, Eto T, Taniguchi S, Ohashi K, Sakamaki H, Morishima Y, Kato K, Miyamura K, Suzuki R, Fukuda T.	Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT.	Bone Marrow Transplant.	49(12),	1505-1512,	2014.
1462012	原著	Kohashi S, Mori T, Hashida R, Kato J, Saburi M, Kikuchi T, Koda Y, Toyama T, Yamane Y, Yamanaka S, Okamoto S.	Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia.	Int J Hematol.	101(1),	102-105,	2014.
1462013	原著	菊池拓、森毅彦,甲田裕也,佐分利益穂,小橋澄子,外山高朗,加藤　淳,橋本統,中塚誠之,海老沼浩利,岡本真一郎.	同種造血幹細胞移植患者における経内頸静脈的肝生検の安全性と有効性の検討　 Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients	臨床血液.	55,	2320-2323,	2014.
1462013	原著	Suzuki Y, Tokimatsu I, Morinaga Y, Sato Y, Takano K, Kohno K, Ogata M, Hiramatsu K, Itoh H, Kadota JI.	A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy.	Clin Chim Acta.	440	7-183,	2014.
1462014	症例報告	Tokuyama K, Okada F, Matsumoto S, Mori H, Ogata M, Omote E, Yamasaki T, Urabe S.	EBV-positive MTX-diffuse large B cell lymphoma in a rheumatoid arthritis patient	Jpn J Radiol.	32,	183-187,	2014.
1462015	症例報告	佐分利益穂,井谷和人,長松顕太郎,宮崎泰彦,大塚英一,卜部省吾,佐分利能生.	Methotrexate/cytarabine大量療法が奏功したSMILE療法抵抗性の節外性NK/T細胞リンパ腫、鼻型.	臨床血液.	55,	120-124,	2014.
1462016	症例報告	油田さや子、森毅彦、加藤淳、甲田裕也、小橋澄子、菊池拓、佐分利益穂、岡本真一郎	同種造血幹細胞移植後のtacrolimusによるナトリウム喪失性腎症.	臨床血液.	54,	2187-191,	2013.
1462017	総説	宮崎泰彦.	Peg-G-CSF製剤への期待.	血液フロンティア.	24,	80-84,	2014.
1462018	総説	池邉太一.	臍帯血移植後早期のウイルス感染症-克服するべき合併症と虎の門病院での取り組み.	医学のあゆみ.	249(7),	594-599,	2014.
1462019	総説	緒方正男.	同種造血細胞移植後のHHV-6再活性化と脳炎.	血液内科.	68 (5),	682-688,	2014.
1462020	著書	平島　詳典,白尾　國昭.	がんに対する薬の使い方.	MEDICAL REHABILITATION.	no.178,	70-74,	2014.
1462021	著書	佐分利益穂,森毅彦.	造血幹細胞移植に特有な合併症.	血液病学.	第2版、第5章:血液疾患の治療 / C造血幹細胞移植,	256-264,	2014.
1462022	著書	Zerr DM , Ogata M.	HHV-6A and HHV-6B in recipients of hematopoietic cell transplantation.	Human Herpesviruses HHV-6A, HHV-6B & HHV-7, Diagnosis and Clinical Management, third edition Chapter 13.		217-229,	2014.